Applied BioCode (TPE:6598) Interest Expense: NT$-1.6 Mil (TTM As of Dec. 2025)

What is Applied BioCode Interest Expense?

Applied BioCode TPE:6598 74 Interest Expense is NT$-1.6 Mil as of Dec. 2025. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$23.34 (Fairly Valued). The stock has 6 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Applied BioCode's interest expense for the three months ended in Dec. 2025 was NT$ -0.8 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$-1.6 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Applied BioCode's Operating Income for the three months ended in Dec. 2025 was NT$ -68.6 Mil. Applied BioCode's Interest Expense for the three months ended in Dec. 2025 was NT$ -0.8 Mil. Applied BioCode did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Applied BioCode (TPE:6598) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Applied BioCode's Interest Expense for the three months ended in Dec. 2025 was NT$-0.8 Mil. Its Operating Income for the three months ended in Dec. 2025 was NT$-68.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2025 was NT$38.8 Mil.

Applied BioCode's Interest Coverage for the quarter that ended in Dec. 2025 is calculated as

Applied BioCode did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Applied BioCode Interest Expense Historical Data

* Premium members only.

The historical data trend for Applied BioCode's Interest Expense can be seen below:

Applied BioCode Interest Expense Chart

Applied BioCode Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-2.87

-2.78

-2.17

-1.43

-1.59

Applied BioCode Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25
Interest Expense	Get a 7-Day Free Trial															-0.28	-0.24	-0.20	-0.33	-0.82

74GF Score

Applied BioCode Corp TPE:6598

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Applied BioCode Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-1.6 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of NT$-1.6 Mil mean?

Applied BioCode (TPE:6598) has a Interest Expense of NT$-1.6 Mil as of Dec. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on Applied BioCode and its competitors.

Is Applied BioCode's Interest Expense too high?

Applied BioCode's current Interest Expense is NT$-1.6 Mil. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Applied BioCode's Interest Expense compare to ABT and SYK?

Applied BioCode's Interest Expense of NT$-1.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Devices & Instruments company?

A good Interest Expense depends on the Medical Devices & Instruments industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Applied BioCode and its competitors. Applied BioCode's current Interest Expense is NT$-1.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Applied BioCode stock overvalued right now?

Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Fairly Valued. The stock's GF Value™ is NT$23.34, compared to a current price of NT$22.85 — trading 2.1% below its estimated fair value. The current Interest Expense is NT$-1.6 Mil. Applied BioCode's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current Interest Expense is NT$-1.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be undervalued. The current stock price of NT$22.85 is trading 2.1% below its estimated GF Value™ of NT$23.34. GuruFocus considers Applied BioCode to be Fairly Valued.

Key valuation signals for TPE:6598:

Interest Expense: NT$-1.6 Mil
GF Value™: NT$23.34 vs. price of NT$22.85 (2.1% below fair value)
GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Applied BioCode Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies TPE:4106 TPE:6934 TPE:6796 TPE:6918 TPE:4155 ROCO:4138 ROCO:6649 TPE:6955 ROCO:7713 ROCO:4161 ABT SYK MDT BSX EW XTER:SHL GEHC DXCM XAMS:PHIA SZSE:300760

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670

Website https://www.apbiocode.com

Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.

74GF Score

Get the complete analysis for TPE:6598

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$22.85

Price

NT$23.34

GF Value

View TPE:6598 Analysis

See Interest Expense data for all stocks →